Publications by authors named "Xing-Kun Tang"
World J Gastroenterol
August 2024
Article Synopsis
- Mesenchymal stem cells (MSCs) show promise in treating liver fibrosis, but their effectiveness is limited by low survival rates and implantation challenges.
- Recent studies suggest that combining MSCs with certain drugs can enhance their therapeutic benefits and slow the progression of liver disease.
- A review of 13 randomized controlled trials found that this combination therapy significantly improves liver function and repairs damaged tissue, although it does not significantly impact serum albumin levels.
